Page last updated: 2024-11-13

lithium perchlorate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lithium perchlorate: stabilizes DNA-polycation complex; RN given refers to parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23665649
CHEMBL ID3613684
MeSH IDM0154275

Synonyms (30)

Synonym
perchloric acid, lithium salt
7791-03-9
lithium perchlorate
AKOS015843727
lithium perchlorate, battery grade, dry, 99.99% trace metals basis
lithium perchlorate, 99.99% trace metals basis
einecs 232-237-2
nsc 106672
perchloric acid, lithium salt (1:1)
q86se98c9c ,
unii-q86se98c9c
perchloric acid lithium salt
lithium perchlorate [mi]
lithium per chlorate
lithiumperchlorate
MHCFAGZWMAWTNR-UHFFFAOYSA-M
CHEMBL3613684
mfcd00011079
lithium perchlorate, anhydrous
DTXSID40872829
lithium perchlorate, saj special grade, >=99.0%
lithium perchlorate, acs reagent, >=95.0%
lithium perchlorate, p.a., acs reagent, 95%
liclo4
lithium perchlorate, trace metals grade 99.9%
Q412015
lithium perchlorate (liclo4 )
li (cl o4)
lithium;perchlorate
L0379

Research Excerpts

Actions

ExcerptReferenceRelevance
"Lithium perchlorate was found to enhance the reaction rate and, at the same time, had a pronounced influence on the chemoselectivity of the reaction."( Transformation of D-(-)-ribose into a natural product-like scaffold via a Lewis acid catalyzed intramolecular hetero-Diels-Alder reaction.
Fuhrer, CA; Häner, R; Messer, R, 2007
)
1.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1244834Antibacterial activity against Staphylococcus epidermidis ATCC 49134 after 18 hrs by serial microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.
AID1244813Antibacterial activity against Staphylococcus aureus ATCC 4163 after 18 hrs by serial microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.
AID1244806Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by serial microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.
AID1244820Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by serial microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.
AID1244827Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by serial microdilution method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (6.82)18.7374
1990's4 (9.09)18.2507
2000's22 (50.00)29.6817
2010's13 (29.55)24.3611
2020's2 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.21 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index68.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]